PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHyperhidrosis
MeSH D006945 - hyperhidrosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D013543:Sweat gland diseases
0 Companies
0 Drugs
Success rate
D006945: 
Hyperhidrosis
$
Success rate
D013547:Gustatory sweating
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieOnabotulinumtoxina Botox  1991-12-09   
AstraZenecaGlycopyrronium, Formoterol Bevespi Aerosphere  2018-12-18   
Budesonide, Glycopyrronium, Formoterol Riltrava Aerosphere  2022-01-06   
Budesonide, Glycopyrronium, Formoterol Trixeo Aerosphere  2020-12-09   
Chiesi FarmaceuticiGlycopyrronium, Beclometasone, Formoterol Trimbow  2017-07-17   
Glycopyrronium, Beclometasone, Formoterol Trydonis  2018-04-26   
IpsenAbobotulinumtoxina Dysport  2009-04-29   
Journey MedicalGlycopyrronium Qbrexza 2028-10-17 2018-06-28   
NovartisIndacaterol, Glycopyrronium, Mometasone Enerzair Breezhaler  2020-07-03   
Glycopyrronium Enurev Breezhaler  2012-09-28   
Glycopyrronium Seebri Breezhaler  2012-09-28   
Glycopyrronium Tovanor Breezhaler  2012-09-28   
Indacaterol, Glycopyrronium Ultibro Breezhaler  2013-09-19   
Indacaterol, Glycopyrronium Ulunar Breezhaler  2014-04-23   
Indacaterol, Glycopyrronium Xoterna Breezhaler  2013-09-18   
Indacaterol, Glycopyrronium, Mometasone furoate Zimbus Breezhaler  2020-07-03   
ProvecaGlycopyrronium Sialanar  2016-09-15   
Clinical Trials
Historical Success Rate
Phase 1
100%
5/5
Phase 2
44%
4/9
Phase 3
100%
6/6
Approved: 2Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
AstraZeneca
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use